ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2727

T Cells Trigger Interstitial Pneumonia in Polymyositis

Akira Takeda1,2, Yasutsugu Fukushima3, Takaji Matsutani4, Yoichiro Haji1, Chisun Min1, Ryo Rokutanda1, Yasuhiro Suyama1, Mitsumasa Kishimoto5, Ken-ichi Yamaguchi1 and Masato Okada6, 1Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, 2Division of Clinical Immunology & Rheumatology, International University of Health and Welfare Hospital, Nasu-shiobara, Japan, 3Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Mibu, Japan, 4Laboratory of Immune Regulation, Wakayama Medical University, Ibaraki, Japan, 5St. Luke's International Hospital, Tokyo, Japan, 6Immuno-Rheumatology Center, St. Luke's International Hospital, tokyo, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Idiopathic Inflammatory Myopathies (IIM), lung and pulmonary fibrosis, Pulmonary Involvement, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T cell Biology in Lupus, Vasculitis, Myositis and Other Autoimmunity

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The lung is frequently affected in connective tissue diseases (CTDs). Polymyositis (PM) is a major CTD characterized by idiopathic inflammatory lesions of muscle and other organs including critical pulmonary involvement. Interstitial lung diseases, mainly interstitial pneumonia (IP), have been recognized in 30-70% of PM patients, which often have a poor prognosis and a high risk of mortality. While the presence of myositis-specific autoantibodies suggests an autoimmune etiology of PM, the pathogenesis of PM-associated IP remains unclear. The aim of this study was to elucidate the role of T cells in this pulmonary complication.  Lung tissue was utilized in this study with the approval of the IRB.

Methods:

We had advantage of a rare opportunity to be able to precisely study the lung tissues which were obtained for the pathodiagnostic purpose by video-assisted thoracoscopy from the cases of earliest-stage IP associated with PM: one patient with IP of early usual IP (UIP) pattern and another patient with IP of nonspecific IP (NSIP) pattern. It lead us to immunohistochemically characterize the phenotype of lung-infiltrating lymphocytes from the lung biopsy specimens, and to analyze T-cell receptor α-chain (TCR Vα) and TCR β-chain (TCR Vβ) variable region repertoires of T-cells infiltrating the lung tissues using a validated adaptor ligation polymerase chain reaction (PCR)-based microplate hybridization assay, comparing these to peripheral blood lymphocytes (PBL). We considered it important to perform TCR analysis from lung tissue in the earliest stage of IP because TCRs diversify with disease progression due to “determinant spreading” in which autoreactive T-cell responses, initiated by a single antigenic epitope, evolve into multiepitopic responses.     

Results:

The study with lung tissues of the initial stage of IP demonstrated substantial pulmonary CD3+ predominated T cell infiltrates. In both cases, patient A (early UIP pattern) and patient B (NSIP pattern), most of the mononuclear cells were CD3+ T-cells, accompanied by a subtle infiltration of B-cells (CD20+), and a minimal number of monocytes (CD19+). Of infiltrating T-cells, more CD4+ than CD8+ cells (in the ratio of four to one) were noted in both patients. The usage of repertoires of TCR Vα/Vβ in the lung differed from those in PBL, with certain TCR V gene families detected more frequently in lung tissue, suggesting a pivotal role for T cells in the pathogenesis of IP associated with PM.  This is the first robust demonstration of selective TCR repertoire usage and its differential expression in lung tissue versus PBL.  As expected, no TCR signals were detected from non-IP lung tissue controls. 

Conclusion:

These findings clearly suggest a pathogenic contribution of organ-specific oligoclonal T cell accumulation through antigen-driven immune responses, implying potential elucidation of causative antigens as well as development of immuno-specific treatments such as molecular-targeted therapies.


Disclosure:

A. Takeda,
None;

Y. Fukushima,
None;

T. Matsutani,
None;

Y. Haji,
None;

C. Min,
None;

R. Rokutanda,
None;

Y. Suyama,
None;

M. Kishimoto,
None;

K. I. Yamaguchi,
None;

M. Okada,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/t-cells-trigger-interstitial-pneumonia-in-polymyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology